Expanding Capacity Eurofins has announced substantial investments in new facilities, including a 300,000-square-foot biopharmaceutical testing center and office expansions, creating opportunities to offer laboratory equipment, instrumentation, and support services for their increased operational capacity.

Diverse Testing Services The company's recent launches, such as GMP PFAS testing for medical devices and chemical safety testing for toys and softlines, indicate ongoing demand for specialized testing solutions, presenting opportunities for tailored laboratory testing and compliance services.

Market Growth Potential Eurofins’ focus on biopharmaceuticals and chemical testing across multiple regulated sectors suggests a strong growth trajectory in healthcare, biotech, and consumer safety markets, ideal for proposing innovative testing technologies and regulatory compliance solutions.

Global Technical Expertise With over 25 years of experience and a global network of specialized laboratories, Eurofins is positioned to expand its technological offerings and consulting services, such as data analytics and digital platforms, to enhance research and regulatory processes.

Synergy with Sustainability Eurofins’ development of unique testing programs for chemicals in consumer products demonstrates an emphasis on sustainability and chemical safety, presenting sales opportunities in eco-friendly testing solutions and environmental impact assessments.